人人人澡人人人妻人人人少妇 ,欧美寡妇性猛交xxx,人人妻人人爽人人澡,久久久

熱門搜索化學品最多只顯示前20條，請點擊“搜索化學品”查看所有結果

CAS登錄號

中文名

英文名

分子結構式

分子式

詳情

供應商

54276-21-0

(+)-氯前列烯醇;
(5Z)-7-[(1R,2R,3R,5S)-2-[(1e,3R)-4-(3-氯苯氧基)-3-羥基-1-丁烯-1-基]-3,5-二羥基環(huán)戊基]

(+)-Cloprostenol;
(5Z)-7-[(1R,2R,3R,5S)-2-[(1e,3R)-4-(3-Chlorophenoxy)-3-hydroxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-5-heptenoic acid

他氟前列素;
(5Z)-7-[(1R,2R,3R,5S)-2-[(1e)-3,3-二氟-4-苯氧基-1-丁烯-1-基]-3,5-二羥基環(huán)戊基]-5-庚烯酸異

Tafluprost;
(5Z)-7-[(1R,2R,3R,5S)-2-[(1e)-3,3-Difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-5-heptenoic acid 1-methylethyl ester

木利替尼;
1-(4-(4-((2-((1e)-2-(4-(三氟甲基)苯基)乙烯基)-4-惡唑基)甲氧基)苯基)丁基)-1H-1,2,3-三氮唑

Mubritinib;
1-(4-(4-((2-((1e)-2-(4-(Trifluoromethyl)phenyl)ethenyl)-4-oxazolyl)methoxy)phenyl)butyl)-1H-1,2,3-triazole

Pitavastatin lactone;
2H-Pyran-2-one,6-[2-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]ethenyl]tetrahydro-4-hydroxy-,[4R-[4a,6b(E)]]-;
(4R,6S)-(4R,6S)-6-[(1e)-2-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]ethenyl]tetrahydro-4-hydroxy-2H-pyran-2-one;
(4R,6S)-(E)-6-[2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-ylethenyl]-4-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one;
NK 104;
NK 104 (lactone);
Nisvastatin;
P 872441;

1,2-Benzenediol,4,4'-[(1e)-1-penten-4-yne-1,5-diyl]bis-;
1,2-Benzenediol,4,4'-(1-penten-4-yne-1,5-diyl)bis-, (E)-;
1,2-Benzenediol,4,4'-[(E)-1-penten-4-yne-1,5-diyl]bis- (9CI);
Rooperol;
trans-Rooperol

1,2,4-Benzenetriol,5-[(1e)-2-(3-hydroxyphenyl)ethenyl]-;
1,2,4-Benzenetriol,5-[2-(3-hydroxyphenyl)ethenyl]-, (E)-;
Roxburghin

1,2,4-Oxadiazole,3-[(1e)-2-[4-(methylsulfonyl)phenyl]ethenyl]-;
1,2,4-Oxadiazole,3-[2-[4-(methylsulfonyl)phenyl]ethenyl]-, (E)-;
1,2,4-Oxadiazole, 3-[p-(methylsulfonyl)styryl]-,(E)- (8CI);
BTI 2571e

1,2,4-Oxadiazole,3-[(1e)-2-[4-(methylsulfinyl)phenyl]ethenyl]-;
1,2,4-Oxadiazole,2-[p-(methylsulfinyl)styryl]-, (E)- (8CI);
1,2,4-Oxadiazole, 3-[2-[4-(methylsulfinyl)phenyl]ethenyl]-,(E)-;
BTI 2286E

1,2,3,4,5-Hexapentaen-1-amine,6-fluoro-N,N-dimethyl-, (1e)-;
1,2,3,4,5-Hexapentaen-1-amine,6-fluoro-N,N-dimethyl-,(1e)-(9CI)

1,2,4-Oxadiazol-3-amine,5-[(1e)-2-(5-nitro-2-furanyl)ethenyl]-;
1,2,4-Oxadiazol-3-amine,5-[2-(5-nitro-2-furanyl)ethenyl]-, (E)-;
1,2,4-Oxadiazole, 3-amino-5-[2-(5-nitro-2-furyl)vinyl]-,(E)- (8CI);
SQ 18116

1,2,4-Oxadiazol-5-amine,3-[(1e)-2-(5-nitro-2-furanyl)ethenyl]-;
1,2,4-Oxadiazol-5-amine,3-[2-(5-nitro-2-furanyl)ethenyl]-, (E)-;
1,2,4-Oxadiazole, 5-amino-3-[2-(5-nitro-2-furyl)vinyl]-,(E)- (8CI);
SQ 18506;
trans-5-Amino-3-[(5-nitro-2-furyl)vinyl]-1,2,4-oxadiazole;
trans-5-Amino-3-[2-(5-nitro-2-furyl)vinyl]-1,2,4-oxadiazole;
trans-5-Imino-3-[2-(5-nitro-2-furyl)vinyl]-D2-1,2,4-oxadiazoline

1,2-Benzenediol,4-[(1e)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]-;
1,2-Benzenediol,4-[(1e)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenyl-1-butenyl]- (9CI);
1,2-Benzenediol, 4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenyl-1-butenyl]-,(E)-;
(E)-3,4-Dihydroxytamoxifen;
3,4-Dihydroxytamoxifen;
ICI 77307

1,2,3-Benzenetriol,5-[(1e)-2-(4-hydroxyphenyl)ethenyl]-

Desmethyl Cerivastatin-O-b-D-glucuronide;
[5-[(1e,3S,5R)-6-Carboxy-3,5-dihydroxy-1-hexenyl]-4-(4-fluorophenyl)-2,6-bis(1-methylethyl)-3-pyridinyl]methyl b-D-Glucopyranosiduronic Acid;
Desmethyl Cerivastatin-O-b-D-glucuronide;
M-4 Metabolit;
[5-[(1e,3S,5R)-6-Carboxy-3,5-dihydroxy-1-hexenyl]-4-(4-fluorophenyl)-2,6-bis(1-methylethyl)-3-pyridinyl]methyl -D-Glucopyranosiduronic Acid;
Desmethyl Cerivastatin-O--D-glucuronide;
M-4 Metabolite

(+)-HIMBACINE;
(+)-HIMBACINE;
HIMBACINE;
(3s-(3-alpha,3a-alpha,4-beta(1e,2(2r*,6s*)),4a-beta,8a-alpha,9a-yl)-3-methyl;
naphtho(2,3-c)furan-1(3h)-one,decahydro-4-(2-(1,6-dimethyl-2-piperidinyl)ethen;
(3s,3ar,4r,4as,8ar,9as)-4-[(1e)-2-[(2r,6s)-1,6-dimethyl-2-piperdinyl]ethenyl]decahydro-3-methyl-naphtho[2,3-c]furan-1(3h)-one;
(3S)-3β-Methyl-4α-[(E)-2-[(2R)-1,6α-dimethyl-2β-piperidinyl]vinyl]-1,3,3aβ,4,4aα,5,6,7,8,8aβ,9,9aβ-dodecahydronaphtho[2,3-c]furan-1-one;
(3S)-3β-Methyl-4α-[(E)-2-[(2R,6S)-1,6-dimethyl-2-piperidinyl]ethenyl]-1,3,3aβ,4,4aα,5,6,7,8,8aβ,9,9aβ-dodecahydronaphtho[2,3-c]furan-1-one;
(3S)-4α-[(E)-2-[(2R,6S)-1,6-Dimethyl-2-piperidinyl]vinyl]-3aβ,4,4aα,5,6,7,8,8aβ,9,9aβ-decahydro-3-methylnaphtho[2,3-c]furan-1(3H)-one

(+)-(3AR,4R,5R,6AS)-六氫-5-羥基-4-[(1e,3R)-3-羥基-4-(3-三氟甲基)苯氧基-1-丁烯基]-2H-環(huán)戊并[B]呋喃-2-

(+)-(3AR,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-[(1e,3R)-3-HYDROXY-4-(3-TRIFLUOROMETHYL)PHENOXY-1-BUTENYL];
(+)-(3AR,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-[(1e,3R)-3-HYDROXY-4-(3-TRIFLUOROMETHYL)PHENOXY-1-BUTENYL]-2H-CYCLOPENTA[B]FURAN-2-ONE;
(+)-FLUPROSTENOL LACTONE DIOL;
(+)-(3AR,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-[(1e,3R)-3-HYDROXY-4-(3-TRIFLUOROMETHYL)PHENOXY-1-BUTENYL]-2H-CYCLOPENTA[B]FURAN-2-ONE;
HYDRIDE-T;
(+)-(3aR,4R,5r,6aS)-Hexahydro-5-hydroxy-4-[(1e,3R)-3-hydroxy-4-(3-trifluoromethyl)phenoxy-1-butenyl]-2H-cyclopenta[b]furan-2-one;
TP-2 (TV-EDI) (Travoprost)

(3AR,4R,5R,6AS)-4-[(1e)-4-(3-氯苯氧基)-3-氧代-1-丁烯-1-基]六氫-5-羥基-2H-環(huán)戊并[B]呋喃-2-酮

ENONE-C;
ENONE-C;
(3aR,4R,5R,6aS)-4-[(1e)-4-(3-Chlorophenoxy)-3-oxo-1-buten-1-yl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-one

福司曲星

FOSTRIECIN SODIUM SALT;
11-tridecatetraenyl)-monosodiumsalt;
antibioticci920sodiumsalt;
antibioticcl1565asodiumsalt;
ci920sodiumsalt;
cl1565asodiumsalt;
PHOSPHOTRIENIN;
(6R)-5,6-DIHYDRO-6-[(1e,3R,4R,6R,7Z,9Z,11e)-3,6,13-TRIHYDROXY-3-METHYL-4-(PHOSPHONOOXY)-1,7,9,11-TRIDECATETRAENYL]-2H-PYRAN-2-ONE SODIUM SALT;
FST

(4R,6S)-6-[(1e)-2-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]ethenyl]-2,2-dimethyl-1,3-diox;
(3R,5S)-Fluvastatin-3,5-acetonide tert-Butyl Ester;
(4R,6S)-6-[(1e)-2-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]ethenyl]-2,2-dimethyl-1,3-dioxane-4-acetic Acid 1,1-Dimethylethyl Ester

{2-Methoxy-4-[(1e)-1-propen-1-yl]phenoxy}(trimethyl)silane

C13H20O2Si

詳情

供應商

日日夜夜撸,人妻无码一区二区不卡无码av,日产亚洲 a,人妻精品久久久久中文字幕69,欧美激情欧美精品一区二区

化工產品